Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15293573 [patent_doc_number] => 20190389922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => PEPTIDES FOR ANGIOGENIC THERAPY [patent_app_type] => utility [patent_app_number] => 16/465808 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465808 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/465808
Peptides for angiogenic therapy Jan 24, 2019 Issued
Array ( [id] => 14581805 [patent_doc_number] => 20190218511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => METHODS AND COMPOSITIONS FOR TARGETING PROGENITOR CELL LINES [patent_app_type] => utility [patent_app_number] => 16/254086 [patent_app_country] => US [patent_app_date] => 2019-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254086 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/254086
METHODS AND COMPOSITIONS FOR TARGETING PROGENITOR CELL LINES Jan 21, 2019 Abandoned
Array ( [id] => 16778033 [patent_doc_number] => 20210115111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => USE OF A PEPTIDE DERIVED FROM THE HUMAN PROTEIN NTIMP3 IN THE TREATMENT OF DIABETIC NEPHROPATHY [patent_app_type] => utility [patent_app_number] => 16/964071 [patent_app_country] => US [patent_app_date] => 2019-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5482 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964071 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/964071
USE OF A PEPTIDE DERIVED FROM THE HUMAN PROTEIN NTIMP3 IN THE TREATMENT OF DIABETIC NEPHROPATHY Jan 20, 2019 Abandoned
Array ( [id] => 16491205 [patent_doc_number] => 10857223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Autologous and allogenic HIV-1 proteins for the treatment of latent HIV-1 infection [patent_app_type] => utility [patent_app_number] => 16/252108 [patent_app_country] => US [patent_app_date] => 2019-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 26 [patent_no_of_words] => 22445 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252108 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/252108
Autologous and allogenic HIV-1 proteins for the treatment of latent HIV-1 infection Jan 17, 2019 Issued
Array ( [id] => 16786110 [patent_doc_number] => 10988522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Proteolically resistant cyclotides with angiotensin 1-7 like activity [patent_app_type] => utility [patent_app_number] => 16/232985 [patent_app_country] => US [patent_app_date] => 2018-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 18510 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16232985 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/232985
Proteolically resistant cyclotides with angiotensin 1-7 like activity Dec 25, 2018 Issued
Array ( [id] => 16557191 [patent_doc_number] => 20210002339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => PEPTIDE AND PHARMACEUTICAL COMPOSITIONS OF SAME FOR USE AS AN ANTIMICROBIAL AND IN CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 16/955370 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955370 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955370
Peptide and pharmaceutical compositions of same for use as an antimicrobial and in cancer treatment Dec 20, 2018 Issued
Array ( [id] => 14716347 [patent_doc_number] => 20190249237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => MODIFIED BIOTIN-BINDING PROTEINS FOR IMMOBILIZATION [patent_app_type] => utility [patent_app_number] => 16/230480 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16230480 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/230480
Modified biotin-binding proteins for immobilization Dec 20, 2018 Issued
Array ( [id] => 17541009 [patent_doc_number] => 11306119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-19 [patent_title] => Peptide bound to PD-L1 and use thereof [patent_app_type] => utility [patent_app_number] => 16/772809 [patent_app_country] => US [patent_app_date] => 2018-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7680 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772809 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/772809
Peptide bound to PD-L1 and use thereof Dec 16, 2018 Issued
Array ( [id] => 18716541 [patent_doc_number] => 11793864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Use of serine protease inhibitors in the treatment of skin diseases [patent_app_type] => utility [patent_app_number] => 16/217957 [patent_app_country] => US [patent_app_date] => 2018-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 23506 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16217957 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/217957
Use of serine protease inhibitors in the treatment of skin diseases Dec 11, 2018 Issued
Array ( [id] => 15038543 [patent_doc_number] => 20190330276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/213885 [patent_app_country] => US [patent_app_date] => 2018-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16213885 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/213885
HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE Dec 6, 2018 Abandoned
Array ( [id] => 17649682 [patent_doc_number] => 11352396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-07 [patent_title] => Antimicrobial peptides and methods of using same [patent_app_type] => utility [patent_app_number] => 16/769025 [patent_app_country] => US [patent_app_date] => 2018-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7594 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769025 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/769025
Antimicrobial peptides and methods of using same Dec 4, 2018 Issued
Array ( [id] => 17727751 [patent_doc_number] => 11384126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-12 [patent_title] => Compositions and methods for inhibiting DHHC-type palmitoyltransferases for cancer treatment [patent_app_type] => utility [patent_app_number] => 16/766942 [patent_app_country] => US [patent_app_date] => 2018-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 33437 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766942 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/766942
Compositions and methods for inhibiting DHHC-type palmitoyltransferases for cancer treatment Nov 29, 2018 Issued
Array ( [id] => 17490445 [patent_doc_number] => 11279734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Solution-phase affinity selection of inhibitors from combinatorial peptide libraries [patent_app_type] => utility [patent_app_number] => 16/206944 [patent_app_country] => US [patent_app_date] => 2018-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 175 [patent_no_of_words] => 46961 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16206944 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/206944
Solution-phase affinity selection of inhibitors from combinatorial peptide libraries Nov 29, 2018 Issued
Array ( [id] => 17490445 [patent_doc_number] => 11279734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Solution-phase affinity selection of inhibitors from combinatorial peptide libraries [patent_app_type] => utility [patent_app_number] => 16/206944 [patent_app_country] => US [patent_app_date] => 2018-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 175 [patent_no_of_words] => 46961 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16206944 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/206944
Solution-phase affinity selection of inhibitors from combinatorial peptide libraries Nov 29, 2018 Issued
Array ( [id] => 16437085 [patent_doc_number] => 20200354411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => Chimeric Molecule for Targeting c-Myc in Cells [patent_app_type] => utility [patent_app_number] => 16/760060 [patent_app_country] => US [patent_app_date] => 2018-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9765 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760060 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/760060
Chimeric Molecule for Targeting c-Myc in Cells Nov 28, 2018 Abandoned
Array ( [id] => 18028938 [patent_doc_number] => 11512111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Yeats inhibitors and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/767434 [patent_app_country] => US [patent_app_date] => 2018-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 57 [patent_no_of_words] => 40431 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767434 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/767434
Yeats inhibitors and methods of use thereof Nov 25, 2018 Issued
Array ( [id] => 16435727 [patent_doc_number] => 20200353052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => COMPOSITION FOR PROMOTING GOBLET CELL PROLIFERATION OR MUCIN SECRETION COMPRISING THYMOSIN BETA 4 OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 16/765929 [patent_app_country] => US [patent_app_date] => 2018-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6731 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765929 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/765929
COMPOSITION FOR PROMOTING GOBLET CELL PROLIFERATION OR MUCIN SECRETION COMPRISING THYMOSIN BETA 4 OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT Nov 22, 2018 Abandoned
Array ( [id] => 14564097 [patent_doc_number] => 20190209655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof [patent_app_type] => utility [patent_app_number] => 16/195184 [patent_app_country] => US [patent_app_date] => 2018-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25148 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195184 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/195184
Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof Nov 18, 2018 Issued
Array ( [id] => 14864939 [patent_doc_number] => 20190282711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => TARGETING PEPTIDES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/188881 [patent_app_country] => US [patent_app_date] => 2018-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14065 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16188881 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/188881
Targeting peptides and methods of use Nov 12, 2018 Issued
Array ( [id] => 14564217 [patent_doc_number] => 20190209715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Plectin-1 Targeted Agents for Detection and Treatment of Pancreatic Ductal Adenocarcinoma [patent_app_type] => utility [patent_app_number] => 16/186078 [patent_app_country] => US [patent_app_date] => 2018-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26592 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16186078 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/186078
Plectin-1 Targeted Agents for Detection and Treatment of Pancreatic Ductal Adenocarcinoma Nov 8, 2018 Abandoned
Menu